Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
AWMF-Leitlinie (2003) Stationäre und ambulante Thromboembolie-Prophylaxe in der Chirurgie und der perioperativen Medizin, AWMF-Leitlinien-Register Nr.002/001, Beilage zu den Mitteilungen der Deutschen Gesellschaft für Chirurgie, Heft 2/2003
Bates SM, Greer IA, Hirsh J, Ginsberg JS (2004) Use of antithrombotic agents during pregnancy. The 7th ACCP conference on antithrombotic and thrombolytic therapy. Chest 126: 627S–644S
Bergqvist D, Agnelli G, Cohen AT et al. (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346: 975–980
Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP (2000) Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med 160: 49–52
Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J (2005) Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost 3: 227–229
Caine GJ, Stonelake PS, Rea D, Lip GYH (2003) Coagulapathic complications in breast cancer. Cancer 98: 1578–1586
Chan WS, Anand S, Ginsberg JS (2000) Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 160: 191–196
Dahlbäck B (2004) APC resistance: what have we learned since 1993? J Lab Med 28: 21–27
Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism. 7th ACCP conference on antithrombotic and thrombolytic therapy. Chest 126: 338S–400S
Greer IA; Nelson-Piercy C (2005) Low-molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood (in press)
Hennessy S, Berlin JA, Kinmann JL, Margolis DJ, Marcus SM, Strom BL (2001) Risk of venous thromboembolism from oral contraceptives containig gestodene and desogestrel versus levonorgestrel: a meta analysis and formal sensitivity analysis. Contraception 64: 125–133
Karim R, Sacher RA (2004) Thrombocytopenia in pregnancy. Curr Hematol Rep 3: 128–133
Kemkes Matthes B (2001) Veränderungen des Gerinnungssystems in der Schwangerschaft. Z Kardiol 90:Suppl 4: 45–48
Kemmeren JM, Algra A, Grobbee DE (2001) Third generation oral contraceptives and risk of venous thrombosis: a meta analysis. BMJ 323: 131–134
Koscielny J, von Tempelhoff GF, Ziemer S, Radtke H, Schmutzler M, Sinha P, Salama A, Kiesewetter H, Latza R (2004a) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 155–166
Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, Salama A, Kiesewetter H, Latza R (2004b) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 195–204
Kupferminc MJ (2005) Thrombophilia and preeclampsia: The evidence so far. Clin Obstet Gynecol 48: 406–415
Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346(10): 752–763
Lindhoff-Last E, Sohn Ch, Ehrly AM, Bauersachs RM (2000) Aktuelles Management der Thrombembolie in Schwangerschaft und Wochenbett. Zentralbl Gynäol 122: 4–17
Lindhoff-Last E (2004) Maternal thrombophilia and obstetric complications. J Lab Med 28: 34–41
Lindqvist PG, Merlo J (2005) Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence? J Thromb Haemost 3: 221–223
Lowe GDO, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H (1997) Epidemiology of coagulation factors, inhibitors and activation markers: 3rd Glasgow MONICA Survey I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 97: 775–784
Mann KG (2003) Thrombin formation. Chest 124: 4S–10S
Mousa HA, Walkinshaw S (2004) Major postpartum haemorrhage. Curr Opin Obstet Gynecol 123:595–603
Nesheim M (2003) Thrombin and fibrinolysis. Chest 124: 33S–39S
Petitti DB (2003) Clinical Practice. Combination estrogen-progestin oral contraceptives, N Engl J Med 349: 1443–1450
Rai R, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with antiphospholipid antibodies. BMJ 314: 253–257
Rey E, Kahn S, David M et al. (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361: 901–908
Sanson BJ, Lensing AW, Prins MH, Ginsberg JS et al. (1999) Safety of lowmolecular-weight heparin in pregnancy: a systemic review. Thromb Haemost 81: 668–672
Schaefer C, Spielmann H (2001) Arzneiverordnung in Schwangerschaft und Stillzeit. Urban & Fischer: München, Jena
Scharrer I (2004) Women with von Willebrand disease. Hämostaseologie 24: 44–49
Schmitt J, Humpich M, Luxembourg B, Lindhoff-Last E (2004) Relationship between endogenous clotting factor activities and BMI, gender, age or oral contraceptive use. Haemostaseologie A77
Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA (2004) Von Willebrand disease in women with menorrhagia: a systematic review. BJOG 111: 734–740
Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG (2003) A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 102: 4306–4311
Willeke A, Gerdsen F, Bauersachs R, Lindhoff-Last E (2002) Rationelle Thrombophilie-Diagnostik. Dtsch Ärztebl 99: A2111–2118
Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results form the Women’s Health Initiative randomized controlled trial. JAMA 288: 321–333
Writing Group for the Women’s Health Initiative Investigators (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291: 1701–1712
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Lindhoff-Last, E. (2006). Blutungs- und Gerinnungsstörungen. In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31105-X_16
Download citation
DOI: https://doi.org/10.1007/3-540-31105-X_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25664-9
Online ISBN: 978-3-540-31105-8
eBook Packages: Medicine (German Language)